Pdt Partners, LLC Merus N.V. Transaction History

Pdt Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$16.48 - $27.23 $331,248 - $547,323	-20,100 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$20.0 - $25.48 $116,380 - $148,268	5,819 Added 40.75%	20,100 $424,000
Q1 2021 May 17, 2021	BUY	$16.14 - $29.11 $230,495 - $415,719	14,281 New	14,281 $298,000
Q4 2020 Feb 16, 2021	SELL	$11.4 - $18.36 $150,240 - $241,966	-13,179 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$10.57 - $16.0 $16,690 - $25,264	1,579 Added 13.61%	13,179 $158,000

Q2 2020 Aug 14, 2020	BUY	$10.5 - $17.36 $121,800 - $201,376	11,600 New	11,600 $187,000

164

47.9M

123K

293K

Ticker MRUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,878,200
Market Cap $2.44B
Description
Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.